P. Clapꢀs et al.
(m, 2H; CH2Ph); 13C NMR (75 MHz, D2O, 25 8C): d=213.7 (CO), 140.5
(C quat), 131.9 (C ar), 131.1 (C ar), 129.1 (C ar), 79.8 (CHOH), 75.4
(CHOH), 71.0 (CH2OP), 40.1 ppm (CH2).
the reaction media. Secondly, both the deprotection of the amino
group and the subsequent reductive amination were performed in a
one-pot procedure by treatment with H2 at 50 psi in the presence of
10% Pd/C. Aqueous solutions of each of the iminocyclitols in their
free-base form were adjusted to pH 6.5, lyophilized, and submitted
to NMR analysis without any further purification.
(3R,4S)-5-O-Benzyl-1-O-phosphonopent-2-ulose disodium salt ((4S)-19):
The title compound was prepared according to the general procedure de-
scribed above. HPLC: k’=4.6. 1H NMR (300 MHz, D2O, 25 8C): d=7.2
3
[13] In previous work (see ref. [7]), the relative configurations at the C-3
and C-4 positions of the linear structures 6–8 could not be unambig-
uously assigned by NMR analysis owing to overlapping signals re-
sulting from the equilibria between the linear adducts and the corre-
sponding cyclic hemiaminals. This was not the case with compound
5; less than 5% of the hemiaminal was formed and the proportion
of both diastereoisomers of the linear compound could be deter-
mined.
(m, 5H; Ph), 4.5 (m, 2H; CH2OP), 4.4 (s, 2H; CH2Ph), 4.3 (d, J(H,H)=
1.8 Hz, 1H; CHOH), 4.1 (m, 3J(H,H)=2.2 Hz, 3J(H,H)=5.5 Hz, 1H;
CHOH), 3.5 ppm (m, 2H; CH2O); 13C NMR (75 MHz, D2O, 25 8C): d=
212.9 (CO), 139.5 (C quat), 131.1 (C ar), 130.9 (C ar), 130.7 (C ar), 78.1,
75.5, 72.6, 72.1, 70.6 ppm (CH and CH2); 1H NMR (300 MHz,
3
[D6]DMSO, 258C): d=7.2 (m, 5H; Ph), 4.8 (dd, 3J(H,H)=6.9, J(H,H)=
18.3 Hz, 2H; CH2OP), 4.5 (s, 2H; CH2Ph), 4.1 (d, 3J(H,H)=1.8 Hz, 1H;
CHOH), 3.9 ppm (dt, 3J(H,H)=6, 3J(H,H)=9.3 Hz, 1H; CH2O); 13C
NMR (75 MHz, [D6]DMSO, 258C): d=207.8 (CO), 138.5 (C quat), 128.3
(C ar), 127.5 (C ar), 127.4 (C ar), 76.1, 72.2, 70.4, 70.3, 69.1 ppm (CH and
CH2).
[14] W.-D. Fessner, G. Sinerius, A. Schneider, M. Dreyer, G. E. Schulz, J.
Badia, J. Aguilar, Angew. Chem. 1991, 103, 596–599; Angew. Chem.
Int. Ed. Engl. 1991, 30, 555–558.
[15] T. Gefflaut, C. Blonski, J. Perie, M. Willson, Prog. Biophys. Mol.
Biol. 1995, 63, 301–340.
[16] W.-D. Fessner, A. Schneider, H. Held, G. Sinerius, C. Walter, M.
Hixon, J. V. Schloss, Angew. Chem. 1996, 108, 2366–2369; Angew.
Chem. Int. Ed. Engl. 1996, 35, 2219–2221.
[17] A. Dalby, Z. Dauter, J. A. Littlechild, Protein Sci. 1999, 8, 291–
297.
[18] D. R. Hall, G. A. Leonard, C. D. Reed, C. I. Watt, A. Berry, W. N.
Hunter, J. Mol. Biol. 1999, 287, 383–394.
(3R,4R)-5-O-Benzyl-1-O-phosphonopent-2-ulose disodium salt ((4R)-
19): The title compound was prepared according to the general procedure
described above. HPLC: k’=4.3. 1H NMR (300 MHz, D2O, 25 8C): d=
7.2 (m, 5H; Ph), 4.5 (m, 2H; CH2OP), 4.4 (s, 2H; CH2Ph), 4.3 (d,
3J(H,H)=1.5 Hz, 1H; CHOH), 4.0 (m, 3J(H,H)=5.1 Hz, 1H; CHOH),
3.4 ppm (m, 2H; CH2O); 13C NMR (75 MHz, D2O, 25 8C): d=212.9
(CO), 139.5 (C quat), 131.1 (C ar), 130.9 (C ar), 130.7 (C ar), 78.1, 75.5,
72.7, 71.7, 71.0 ppm (CH and CH2).
[19] A. R. Plater, S. M. Zgiby, G. J. Thomson, S. Qamar, C. W. Wharton,
A. Berry, J. Mol. Biol. 1999, 285, 843–855.
[20] C.-H. Wong, D. P. Dumas, Y. Ichikawa, K. Koseki, S. J. Danishefsky,
B. W. Weston, J. B. Lowe, J. Am. Chem. Soc. 1992, 114, 7321–7322.
[21] Y. F. Wang, D. P. Dumas, C.-H. Wong, Tetrahedron Lett. 1993, 34,
403–406.
[22] T. Sifferlen, A. Defoin, J. Streith, D. Le Nouen, C. Tarnus, I.
Dosbaa, M.-J. Foglietti, Tetrahedron 2000, 56, 971–978.
[23] A. Defoin, T. Sifferlen, J. Streith, I. Dosbaa, M.-J. Foglietti, Tetrahe-
dron: Asymmetry 1997, 8, 363–366.
[24] C.-H. Wong, R. Alajarin, F. Moris-Varas, O. Blanco, E. Garcia-Jun-
ceda, J. Org. Chem. 1995, 60, 7360–7363.
Acknowledgements
Financial support from the Spanish CICYT (PPQ2002-04625-CO2-01 and
BQU2003-01677) is acknowledged. J.C. acknowledges the CSIC for the
I3P predoctoral scholarship. We thank Prof. Josep Lꢊpez-Santꢅn and the
team at the Chemical Engineering Department, Universitat Autꢃnoma
de Barcelona, for the supply of FucA aldolase. The authors gratefully ac-
knowledge Dr. G. E. Schulz and Dr. A. C. Joerger for providing the coor-
dinates for the FucA model, which include the induced fit of the C-termi-
nal tail.
[25] M. Mitchell, L. Qaio, C.-H. Wong, Adv. Synth. Catal. 2001, 343,
596–599.
[26] A. C. Joerger, C. Gosse, W.-D. Fessner, G. E. Schulz, Biochemistry
2000, 39, 6033–6041.
[1] T. D. Machajewski, C.-H. Wong, Angew. Chem. 2000, 112, 1406–
1430; Angew. Chem. Int. Ed. 2000, 39, 1353–1374.
[2] W.-D. Fessner, V. Helaine, Curr. Opin. Biotechnol. 2001, 12, 574–
586.
[3] W.-D. Fessner, C. Walter, Top. Curr. Chem. 1996, 184, 97–194.
[4] H. J. M. Gijsen, L. Qiao, W. Fitz, C.-H. Wong, Chem. Rev. 1996, 96,
443–473.
[5] C.-H. Wong, R. L. Halcomb, Y. Ichikawa, T. Kajimoto, Angew.
Chem. 1995, 107, 453–474; Angew. Chem. Int. Ed. Engl. 1995, 34,
412–432.
[6] R. Schoevaart, F. vanRantwijk, R. A. Sheldon, J. Org. Chem. 2001,
66, 4559–4562.
[27] The stereochemistry of each chromatographic peak was identified
by applying NMR techniques to purified samples of the major dia-
stereoisomers and to diastereomeric mixtures of the minor ones.
[28] M. K. Dreyer, G. E. Schulz, J. Mol. Biol. 1996, 259, 458–466.
[29] A. C. Joerger, C. Mueller-Dieckmann, G. E. Schulz, J. Mol. Biol.
2000, 303, 531–543.
[30] Kindly provided by G. E. Schulz and A. C. Joerger.
[31] T. A. Halgren, J. Comput. Chem. 1996, 17, 490–519.
[32] D. Qui, S. Shenkin, F. P. Hollinger, W. C. Still, J. Phys. Chem. A
1997, 101, 3005–3014.
[33] W. C. Still, A. Tempczyk, R. C. Hawley, T. Hendrickson, J. Am.
Chem. Soc. 1990, 112, 6127–6129.
[34] M. Schaefer, M. Karplus, J. Phys. Chem. 1996, 100, 1578–1599.
[35] P. A. Nielsen, T. Liljefors, J. Comput.-Aided Mol. Des. 2001, 15,
753–763.
[7] L. Espelt, T. Parella, J. Bujons, C. Solans, J. Joglar, A. Delgado, P.
Clapꢀs, Chem. Eur. J. 2003, 9, 4887–4899.
[8] FucA was produced by the Department of Chemical Engineering,
Universitat Autꢃnoma de Barcelona, within the framework of a col-
laborative CYCIT project (PPQ2002-04625-CO2-01).
[9] L. Espelt, P. Clapꢀs, J. Esquena, A. Manich, C. Solans, Langmuir
2003, 19, 1337–1346.
[10] R. L. Pederson, J. Esker, C.-H. Wong, Tetrahedron 1991, 47, 2643–
2648.
[11] W.-D. Fessner, J. Badia, O. Eyrisch, A. Schneider, G. Sinerius, Tetra-
hedron Lett. 1992, 33, 5231–5234.
[12] Iminocyclitols were obtained from compounds 5–8 in two steps
(Scheme 1). Firstly, the phosphate group was removed by treatment
with acid phosphatase followed by desalting by RP-HPLC. No base-
line separation of the putative diastereoisomers was observed by an-
alytical RP-HPLC. Therefore, the purpose of the purification step
was to isolate the aldol adducts from the other species present in
[36] F. I. Auzanneau, E. Sourial, J. M. Schmidt, M. Feher, Can. J. Chem.
2002, 80, 1088–1095.
[37] S. Perez, A. Imberty, S. B. Engelsen, J. Gruza, K. Mazeau, J. Jime-
nez-Barbero, A. Poveda, J. F. Espinosa, B. P. van Eyck, G. Johnson,
A. D. French, M. Louise, C. E. Kouwijzer, P. D. J. Grootenuis, A.
Bernardi, L. Raimondi, H. Senderowitz, V. Durier, G. Vergoten, K.
Rasmussen, Carbohydr. Res. 1998, 314, 141–155.
[38] W. Fitz, J.-R. Schwark, C.-H. Wong, J. Org. Chem. 1995, 60, 3663–
3670.
[39] S.-H. Jung, J.-H. Jeong, P. Miller, C.-H. Wong, J. Org. Chem. 1994,
59, 7182–7184.
1400
ꢄ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2005, 11, 1392 – 1401